Correlation Analysis of Platelet Count with Mean Platelet Volume to Platelet Count Ratio (MPR) in Covid-19 Patients

Authors

  • Putu Ristyaning Ayu Sangging
  • Risti Graharti
  • Ridha Riano Fathunnisa Medical Faculty, Lampung University

DOI:

https://doi.org/10.53089/medula.v13i1.567

Keywords:

Covid-19, Jumlah Trombosit, Mean platelet volume-to-platelet ratio

Abstract

Coronavirus disease 2019 (Covid-19) is an infectious disease caused by SARS-CoV-2. The number of Covid-19 cases in Indonesia until November 2022 reached 6.7 million confirmed cases of Covid-19 and 160 thousand of them died. In treating Covid-19 patients quickly and accurately and reducing mortality from Covid-19, biomarkers are needed to predict patient mortality. Platelets, Mean Platelet Volume (MPV) and Mean Platelet Volume-To-Platelet Ratio (MPR) have been studied extensively and are thought to be used as predictors of the severity of Covid-19 patients. The design of this study was an observational analytic study with a cross-sectional approach which was carried out on 60 confirmed Covid-19 patients for the January-December 2021 period at Bandar Negara Husada Hospital. Based on the statistical analysis, the average platelet count was 260.5 and the MPR value was 0.04, and the results of the Pearson bivariate correlation analysis obtained r = 0.850 and p = 0.005. This study showed that there is a relationship between platelet count and MPR as a predictor of mortality and there is a difference between platelet count and MPR values in Covid-19 patients.

Author Biographies

Putu Ristyaning Ayu Sangging

 

 

Risti Graharti

 

   

Ridha Riano Fathunnisa, Medical Faculty, Lampung University

 

 

References

Raja RK, Nguyen-Tri P, Balasubraman G, et al. SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. Appl Nanosci. 2021;10(6):1900-1910. doi:10.1007/s13204-021-01900-w

Wools K, Menachemi N, Yiannoutsos CT, et al. Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(29):960-964. doi:10.15585/mmwr.mm6929e1

Asakura H. Diversity of disseminated intravascular coagulation and selection of appropriate treatments. Int J Hematol. 2020;113(1):10-14. doi:10.1007/s12185-020-03030-5

Kemenkes RI. Analisis Data COVID-19 Indonesia: Update per 19 Januari 2022. Satuan Tugas Penanganan Covid-19; 2020.

BNPB. Pedoman Penanganan Cepat Medis dan Kesehatan Masyarakat Covid-19 di Indonesia. 23 Maret. Published online 2020:1-38. http://www.covid19.go.id

Lippi G, Henry BM, Sanchis-Gomar F. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). SAGE Journals. 2020;27(9):906-908. doi:10.1177/2047487320916823

Gumus H, Demir A, Yükkaldıran A. Is mean platelet volume a predictive marker for the diagnosis of COVID-19 in children? Int J Clin Pr. 2021;75(4):e13892. doi:10.1111/ijcp.13892.

Zhao X, Wang K, Zuo P, et al. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients—indications for predictive, preventive, and personalized medical approach. EPMA J. 2020;11(2):139-145. doi:10.1007/s13167-020-00208-z

Chen Z, Wang C, You D, Zhao S, Zhu Z. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis A meta-analysis. Medicine (Baltimore). 2020;99(1):e19388. doi:10.1097/MD.0000000000019388

Li H, Wang S, Zhong F, et al. Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China. Front Med. 2020;7(April):1-6. doi:10.3389/fmed.2020.00190

Zhang X Bin, Hu L, Ming Q, et al. Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis. PLoS One. 2021;16(1 January):1-15. doi:10.1371/journal.pone.0246030

Kemenkes RI. Pedoman Pencegahan Dan Pengendalian Coronavirus Disease (COVID-19). Kementerian Kesehatan RI; 2020.

Qu R, Ling Y, Xiao W, et al. Platelet ‐ to ‐ lymphocyte ratio is associated with prognosis in patients with coronavirus disease ‐ 19. 2020;(March):1533-1541. doi:10.1002/jmv.25767

Claushuis TAM, Veen AIP Van Der, Horn J, et al. Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and sepsis Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and sepsis. Platelets. 2019;30(3):296-304. doi:10.1080/09537104.2018.1445841

Willim HA, Hardigaloeh AT, Supit AI. Koagulopati pada Coronavirus Disease -2019 (COVID-19): Tinjauan pustaka. 2020;11(3):749-756. doi:10.15562/ism.v11i3.766

Hasma R, Rikarni, Yulia D. Analisis Jumlah Trombosit Pada Pasien Terinfeksi Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). Maj Kedokt Andalas. 2021;44(5):39-46. doi:10.25077/mka.v44.i5.p316-324.2021

Fois AG, Paliogiannis P, Scano V, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. 2020;(December 2019):1-13.

Zhong Q, Peng J. Mean platelet volume / platelet count ratio predicts severe pneumonia of COVID-19. 2021;(August 2020):1-9. doi:10.1002/jcla.23607

Liu H, Wang Z, Sun H, Teng T, Li Y, Zhou X. Thrombosis and Coagulopathy in COVID-19 : Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention. 2021;7(January):1-10. doi:10.3389/fcvm.2020.599334

Wool GD, Miller JL. The Impact of COVID-19 Disease on Platelets and Coagulation. 2021;60637:15-27. doi:10.1159/000512007

Published

2023-01-30

How to Cite

Sangging, P. R. A., Graharti, R., & Fathunnisa, R. R. (2023). Correlation Analysis of Platelet Count with Mean Platelet Volume to Platelet Count Ratio (MPR) in Covid-19 Patients. Medical Profession Journal of Lampung, 13(1), 179-184. https://doi.org/10.53089/medula.v13i1.567

Issue

Section

Artikel

Most read articles by the same author(s)

1 2 3 4 > >>